Published in Trop Med Int Health on January 01, 2014
RE: Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults by JM Nachega et al. (2013), TMIH 18, pp 53–57. Trop Med Int Health (2014) 0.76
Primary and Secondary HIV Prevention Among Persons with Severe Mental Illness: Recent Findings. Curr HIV/AIDS Rep (2015) 0.75
Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08
Bikunin and its emerging role in the modulation of tumor invasion and metastasis. J Surg Res (2012) 1.41
Carnosic acid and its inhibitory effect on tumor growth in systemic malignancies. Oral Dis (2012) 1.39
AMACR: an emerging diagnostic and prognostic tool in systemic malignancies. Int Urol Nephrol (2013) 1.39
Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors. Cancer Chemother Pharmacol (2013) 1.11
The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy. Korean J Intern Med (2013) 1.10
Mounier-Kuhn syndrome: a rare and often overlooked cause of bronchial dilation and recurrent respiratory tract infections. J Bras Pneumol (2014) 1.09
Prohibitin and its rapidly emerging role as a biomarker of systemic malignancies. Hum Pathol (2013) 1.09
AKR1B10 and its emerging role in tumor carcinogenesis and as a cancer biomarker. Int J Cancer (2012) 1.08
Letter to the Editor regarding 'Ciglitazone and its emerging role as a potent anti-neoplastic agent'. Int J Pediatr Otorhinolaryngol (2013) 1.08
Letter to the Editor: glioma grade. J Neurosurg (2013) 1.08
Comment on isolation and identification of compounds from Penthorum chinense Pursh with antioxidant and antihepatocarcinoma properties: pinocembrin and its rapidly emerging neuroprotective effects. J Agric Food Chem (2013) 1.08
Cilostazol and its emerging benefits in gastroenterology besides its attenuating effect on indomethacin-induced small intestinal injury. Scand J Gastroenterol (2012) 1.08
The potential role of vitamins in the management of Chagas disease. Rev Soc Bras Med Trop (2013) 1.08
In Regard to Reuther et al. Int J Radiat Oncol Biol Phys (2013) 1.07
Sarcoidosis-associated fatigue: an often forgotten symptom. Expert Rev Clin Immunol (2013) 1.07
Claudin-7 expression and its association with tumor progression in systemic malignancies. Hum Pathol (2013) 1.07
Emerging new markers of toxic epidermal necrolysis. J Intensive Care Med (2013) 1.07
Rare side effects of subcutaneous methotrexate therapy. J Rheumatol (2013) 1.07
Re: The bone-promoting actions of formononetin in established osteopenia. Menopause (2013) 1.07
Ophthalmic complications of microscopic polyangiitis: an often overlooked disease entity. J Stroke Cerebrovasc Dis (2013) 1.07
rs4072037 polymorphisms and their role in gastrointestinal carcinogenesis. Respir Med (2012) 1.07
CD83 antigen expression and its role in the progression of systemic malignancies. Sao Paulo Med J (2013) 1.07
Rare serious complications of erlotinib therapy. Acta Neurochir (Wien) (2013) 1.07
Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas. Expert Opin Ther Targets (2012) 1.07
Nestin and its emerging role in tumor progression and carcinogenesis in systemic tumors besides pancreatic carcinomas. Med Mol Morphol (2013) 1.06
The genetics of moyamoya disease: recent insights into the pathogenesis of the disease. Neurosurgery (2013) 1.06
Green propolis and its inhibitory effect on tumor growth in different systemic malignancies. Food Chem Toxicol (2013) 1.06
Emerging neuroprotective effects of N-palmitoylethanolamide besides its significant antinociceptive effects. Pain Med (2013) 1.06
Hepatic rupture: a rare but serious complication of HELLP syndrome. J Perinat Med (2014) 1.06
Ezrin and its emerging role in tumor progression in systemic malignancies. Cryobiology (2012) 0.90
Vitamin C for attenuating postherpetic neuralgia pain: an emerging treatment alternative. J Headache Pain (2012) 0.84
Systemic and psychiatric disorders associated with polymorphisms of the P2RX7 gene. Am J Med Genet B Neuropsychiatr Genet (2009) 0.83
Cucurbitacin B and its rapidly emerging role in the management of systemic malignancies besides lung carcinomas. Cancer Biother Radiopharm (2013) 0.83
Guggulsterone: a potent farnesoid X receptor antagonist and its rapidly evolving role as a systemic anticarcinogenic agent. Hepatology (2008) 0.81
Neuroprotective effects of edaravone: recent insights. J Neurol Sci (2013) 0.81
IMP3: a new and important biomarker of systemic malignancies. Clin Cancer Res (2008) 0.81
Zoledronic acid and its accentuating effect on tumor radiosensitivity. Oncologist (2013) 0.80
Bafilomycin A1 and its attenuating effect on tumour growth in systemic malignancies, especially gastrointestinal malignancies. Clin Sci (Lond) (2013) 0.80
Green tea: beneficial effects on cholesterol and lipid metabolism besides endothelial function. Eur J Cardiovasc Prev Rehabil (2008) 0.79
The HPV vaccine and behavioral disinhibition. J Adolesc Health (2008) 0.79
Emerging clinical and therapeutic applications of Nigella sativa in gastroenterology. World J Gastroenterol (2009) 0.79
Dl-3-n-butylphthalide and its emerging beneficial effects in neurology. Chin Med J (Engl) (2012) 0.79
TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors. Tumour Biol (2012) 0.78
Pycnogenol: a rapidly expanding role in the management of systemic diseases besides dysmenorrhea. J Reprod Med (2009) 0.78
Role of altered expression of Nedd4L in the pathogenesis of systemic malignancies. Int J Exp Pathol (2012) 0.78
The emerging anti-proliferative role of Nutlin-3 in the pathogenesis of systemic malignancies. Cancer Biol Ther (2012) 0.78
The emerging antineoplastic effects of paeoniflorin. Anticancer Drugs (2013) 0.77
Beyond interstitial lung disease: the rapidly evolving role of Calgranulin B as a biomarker of systemic malignancies. Inflammation (2009) 0.77
Icariin and its emerging role in the treatment of osteoporosis. Chin Med J (Engl) (2013) 0.77
Butein and its emerging anti-proliferative and pro-apoptotic effects in systemic malignancies. Curr Eye Res (2013) 0.77
Obesity and the risk for non-Hodgkin lymphoma. Int J Cancer (2008) 0.77
Emerging new prognostic markers of gastric tumors besides PTK7. J Surg Oncol (2012) 0.77
Beyond rheumatoid arthritis: the close association between interstitial cystitis and Sjogren's syndrome. Neurourol Urodyn (2013) 0.77
Neuroprotective effects of paeoniflorin: an emerging concept in neurology. Folia Neuropathol (2013) 0.77
Tectorigenin and its inhibitory effects on tumor growth in systemic malignancies. Immunopharmacol Immunotoxicol (2013) 0.77
Interleukin-6 antagonists for the management of hypertension. Hypertension (2007) 0.77
Pterostilbene and its emerging antineoplastic effects: a prospective treatment option for systemic malignancies. Am J Surg (2013) 0.77
The role of vitamin D supplementation in HIV: an often forgotten perspective. Climacteric (2011) 0.77
The emerging role of hOGG1 Ser326Cys polymorphisms in gastrointestinal carcinogenesis. Eur J Gastroenterol Hepatol (2013) 0.77
Anti-neoplastic effects of puerarin in systemic malignancies besides colon carcinomas. Int J Pharm (2013) 0.77
Leukocyte telomere length and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2013) 0.77
Evaluation of scrotal masses. Am Fam Physician (2008) 0.77
Comorbidities associated with leptin and psoriasis. J Drugs Dermatol (2013) 0.76
Nicorandil and its associated gastrointestinal side effects. Pacing Clin Electrophysiol (2013) 0.76
Pain-ameliorating effects of minocycline: an emerging treatment modality. J Neurosci Res (2012) 0.76
Osteopontin: a major player in the pathogenesis of endocrine and systemic diseases. Endocr J (2008) 0.76
Smad7 gene transfer therapy: therapeutic applications beyond colonic fibrosis. Eur J Clin Invest (2008) 0.76
Association of chemokine CCL5 and systemic malignancies. J Hum Genet (2008) 0.76
The rapidly emerging role of zerumbone in attenuating tumor growth in systemic malignancies. Mol Nutr Food Res (2012) 0.76
Emerging role of IEX-1 in tumor pathogenesis and prognosis. Ultrastruct Pathol (2012) 0.76
Inhibition of HDAC6-dependent carcinogenesis: emerging, new therapeutic options besides belinostat. Int J Cancer (2009) 0.76
Disulfiram and its emerging role as an adjunctive anti-neoplastic agent. Chem Biol Interact (2013) 0.76
Opioid/naloxone prolonged release combinations for opioid induced constipation. World J Gastroenterol (2012) 0.76
Lubiprostone: clinical applications beyond constipation. World J Gastroenterol (2009) 0.76
Antidepressants as an often overlooked therapeutic option for the treatment and management of arthritis pain: comment on the article by Wolfe and Michaud. Arthritis Care Res (Hoboken) (2010) 0.76
Erythropoietin and its emerging neuroprotective effects. Int J Neurosci (2013) 0.76
Tea consumption and the risk for pancreatic cancer. Pancreas (2009) 0.75
Prolactin and systemic malignancies: a close association. Fam Cancer (2008) 0.75
Diabetes mellitus and its association with esophageal disorders besides motility dysfunction. J Gastroenterol (2009) 0.75
Vesicoureteral reflux: genetic associations besides the Hinman syndrome. Clin Exp Nephrol (2008) 0.75
Tanshinone IIA: a potent, natural anti-carcinogenic agent for the management of systemic malignancies. Chin J Integr Med (2009) 0.75
Sivelestat and its role in tissue reperfusion injury. Eur J Cardiothorac Surg (2008) 0.75
Exemestane: the dawn of a new era in breast cancer treatment. J Cancer Res Clin Oncol (2008) 0.75
Diclofenac patch: clinical applications beyond pain control. J Pain Symptom Manage (2010) 0.75
Clinical and therapeutic applications of Nigella in the management of tropical infectious disorders besides Schistosomiasis. Rev Inst Med Trop Sao Paulo (2009) 0.75
The rapidly evolving role of anakinra in dermatology: a double-edged sword. J Am Acad Dermatol (2008) 0.75
Triptolide and management of systemic malignancies besides pancreatic carcinomas. World J Gastroenterol (2009) 0.75
Atorvastatin and celecoxib: a future role in cancer chemoprevention. Int J Cancer (2008) 0.75
The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas. Int J Cancer (2009) 0.75
Psychological associations of irritable bowel syndrome besides panic disorder: an often overlooked reality. Scand J Gastroenterol (2009) 0.75
Adiponectin and its role in gastrointestinal carcinogenesis. Am J Gastroenterol (2009) 0.75
Procalcitonin and its utility as a diagnostic and prognostic assay in patients with renal dysfunction and immunosuppressive conditions. J Infect Chemother (2009) 0.75
Examination of the skin in patients with gynecomastia. Pediatr Endocrinol Rev (2007) 0.75
Anakinra and its rapidly expanding role in management of nonarthritic systemic disorders. J Rheumatol (2009) 0.75
Management of oral lichen planus: treatment of steroid refractory lesions. Maturitas (2008) 0.75
Comment on "Therapeutic targeting of Syk in autoimmune diabetes". J Immunol (2011) 0.75
Alzheimer's disease: a major challenge in the effective treatment of depression in the elderly. Prev Chronic Dis (2008) 0.75
Omega-3 fatty acids and their rapidly evolving role in the management of psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.75
Management of borderline personality disorder: emerging, new pharmacological and non-pharmacological strategies. Acta Psychiatr Scand (2008) 0.75